Section : Patient care
Since its creation in 1986, the Eating Disorders Program (EDP) has offered specialized clinical services for people 18 years and older who suffer from anorexia nervosa or bulimia nervosa.
Section : Patient care
A multidisciplinary team Ashok Malla, MD, FRCPC, psychiatrist, director, PEPP-Montréal Ridha Joober, MD, PhD, psychiatrist, assistant director, PEPP-Montréal Evangeline Smith, clinical-administrative chief, PEPP-Montréal
Section : Patient care
The Clinic for Assessment of Youth at Risk (CAYR) is a sub-program of PEPP-Montréal and accepts youth between 14 and 30 years of age who have never experienced a psychotic episode but who show signs of increased risk for developing psychosis.
Section : Patient care
The Anxiety Disorders Clinic is a superspecialized (third-line) consultation, assessment and treatment service for people between the ages of 18 and 65 who suffer from one or multiple anxiety disorders.
Section : Patient care
The Bipolar Disorders Program is a superspecialized (third-line) consultation and treatment service for adults aged 18 to 65 who suffer from refractory bipolar disorders.
Section : Patient care
The Mood, Anxiety and Impulsivity Disorders Program at the Douglas Institute provides care to people aged 18 to 65 years with a mood disorder such as Bipolar disorders or Depressive and suicide disorders.
Section : Patient care
The Geriatric Psychiatry Program at the Douglas Institute provides services to clients aged 65 and older and to adults younger than 65 with a geriatric profile. The program covers psychiatric diagnoses such as: mood disorders anxiety di
Section : Patient care
Outpatient clinics for children 18 and undre include the Pervasive Developmental Disorders (PDD) Diagnostic Clinic, the Depressive Disorders Clinic and the Child Psychiatry Outpatient Clinic.
Section : Patient care
The Child Psychiatry Program at the Douglas Institute offers a range of bilingual services to youth aged 0 to 17 years and their families.
Section : Research
Joseph Rochford examines how antidepressants change behavioral and biological mechanisms involved in coping with stress.